Trade Summary

3 days ago, Rhodes Jason P, serving as Dir at Dyne Therapeutics, Inc. (DYN), sold 267,760 shares at $21.09 per share, for a total transaction value of $5,646,496.80. Following this transaction, Rhodes Jason P now holds 1,081,044 shares of DYN.

This sale represents a 19.85% decrease in Rhodes Jason P's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, June 23, 2026 and publicly disclosed via SEC Form 4 filing on Friday, June 26, 2026 at 8:40 AM ET, 3 days after the trade was made.

Dyne Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.